Onderneming InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm
Aandelen
SE0008966295
Farmaceutische producten
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals for Immunological Diseases
100,0
%
| 0 | nan % | 98 | 100,0 % | - |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| - | - | 98 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01-01-23 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01-05-17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Eva Arlander
PRN | Corporate Officer/Principal | 60 | 02-05-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01-01-16 |
Director/Board Member | 68 | 01-01-11 | |
Chairman | 72 | 01-01-11 | |
Karin Bernadotte
BRD | Director/Board Member | 61 | 01-01-22 |
Marlene Forsell
BRD | Director/Board Member | 48 | 01-04-20 |
Director/Board Member | 56 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 532 687 650 | 332 794 895 ( 62,47 %) | 0 | 62,47 % |
Bedrijfsgegevens
InDex Pharmaceuticals Holding AB
Berzelius vaeg 13
171 65, Solna
+46 8 12 20 38 50
http://www.indexpharma.com![Adres InDex Pharmaceuticals Holding AB (publ)](https://cdn.zonebourse.com/static/address/111327676.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+47,51% | 765 mld. | |
-6,79% | 354 mld. | |
+19,37% | 331 mld. | |
+8,72% | 299 mld. | |
+18,87% | 248 mld. | |
-1,96% | 219 mld. | |
+11,11% | 216 mld. | |
+4,55% | 164 mld. | |
-2,67% | 162 mld. |